31 results
10-K
2023 FY
EX-4.14
SKYE
Skye Bioscience Inc
Annual report
21 Mar 24
8:41pm
8-K
EX-4.1
SKYE
Skye Bioscience Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-4.1
SKYE
Skye Bioscience Inc
29 Jan 24
Skye Bioscience Announces $50.25 Million Private Placement Equity Financing
8:02am
8-K
EX-4.3
SKYE
Skye Bioscience Inc
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.2
SKYE
Skye Bioscience Inc
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.1
adqjizjzkarzt
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
8-K
EX-4.3
jd25apez591d1wdktivd
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.1
z73191fd8v91 4jb2
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.2
ahc145dq
28 Sep 21
Skye Bioscience Announces $7.0 Million Registered Direct Offering
8:45am
8-K
EX-4.1
i5thugygio2
5 Aug 20
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
12:00am
8-K
EX-4.2
cmbaj0gt68foijru
5 Aug 20
Emerald Bioscience Raises approximately $7.0 Million in Upsized Registered Offering
12:00am
8-K
EX-4.1
f4a9eam2q
21 Nov 19
Emerald Bioscience Announces $2.0 Million Registered Direct Offering
5:21pm
S-8
EX-4.2
pg6o239j
16 Oct 18
Registration of securities for employees
4:36pm